George Millen: Unscripted

From 68th to 16th on Fortune's innovation list, Infobip's leap isn't just a number. It's a story of aggressive AI, geopolitical alignment, and a 20-year journey.

UID's takeover of AEG ID merges American lab-tech precision with German industrial might, creating a new force in the booming global RFID and automation market.

By securing legal backing for its battery systems' tax credit eligibility, FranklinWH has navigated complex federal rules, setting a new bar for competitors.

A new 16,000 sq ft warehouse in Texas aims to revolutionize Burckhardt Compression's U.S. service, promising same-day shipping and enhanced maintenance.

As AI and fake reviews erode consumer confidence, Loox launches Reviewers.com to generate authentic video reviews. A deep dive into a high-stakes play.

As lawsuits plague synthetic weed killers, Akron-based Lanaturo unveils Salacia, the first selective organic herbicide guided by AI, shaking up the lawn care industry.

In Las Vegas, IQSTEL is on a mission to woo institutional investors. With a massive acquisition and a new buyback, can it fix its valuation problem?

As AI incidents surge over 200%, a cyber resilience veteran is launching a command center to contain the chaos. It’s a new frontier of corporate risk.

A landmark deal between Trading Technologies and Kalshi is set to unlock prediction markets for institutional investors, leveraging advanced tools for a new era of risk management.

As the World Cup kicks off, 115 Chinese-made trains are Mexico's transit backbone. It's a high-stakes test of tech, a geopolitical play, and a PR coup.

CTS Corp's new TSX Crystal integrates a thermistor, a move targeting the multi-billion dollar precision timing market for 5G, auto, and medical tech.

A utility's summer water-saving tips are more than just advice; they're a signal of Illinois' precarious resource reality and a test of corporate strategy.

A record $1.15M campaign for blood cancer reveals a new playbook where executive influence, not just corporate checks, drives profound social impact.

As new federal work rules loom for Indiana's Medicaid members, MHS is investing millions in a workforce program. Is it a proactive lifeline or a new corporate playbook?

A guidance cut at Sanuwave reveals a deeper crisis in wound care, driven by CMS policy shifts that are fueling a disruptive secondary equipment market.

A new surgical method called SMART, developed at Delray Medical Center, uses biological scaffolds to overcome the failure of sutures in critical muscle injuries.

As Latus Bio advances its Huntington's therapy to clinic, new CBO Bethany Mancilla brings a history of high-value deals to fuel the company's growth.

Mars hits a 100% renewable US energy milestone, but is it a true blueprint for corporate climate action? A deep dive into the story behind the numbers.

Tiny biotech HCW Biologics reports promising early data for its alopecia drug. But with a small sample size and big pharma rivals, is this a true breakthrough?

Bruce Eaton's appointment as Chairman at Broken String isn't just a new hire; it's a strategic move to make its INDUCE-seq technology the industry's gold standard.